We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+13.61%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$131B
AUM Growth
+$4.38B
(+3.5%)
Cap. Flow
-$8.55B
Cap. Flow
% of AUM
-6.54%
Top 10 Holdings %
Top 10 Hldgs %
31.78%
Holding
338
New
5
Increased
60
Reduced
234
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$985M |
| 2 |
Amazon
AMZN
|
+$718M |
| 3 |
Fair Isaac
FICO
|
+$244M |
| 4 |
ConocoPhillips
COP
|
+$233M |
| 5 |
IDEX
IEX
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.06B |
| 2 |
Eli Lilly
LLY
|
+$1.01B |
| 3 |
Oracle
ORCL
|
+$929M |
| 4 |
KLA
KLAC
|
+$882M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$494M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.46% |
| 2 | Healthcare | 24.26% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Industrials | 11.4% |
| 5 | Financials | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OS
301
DELISTED
OneStream Inc
OS
| $1.9M | ﹤0.01% |
102,900
-3,000
| -3% | -$65.9K |
|
302
Stratasys
SSYS
$761M
| $1.85M | ﹤0.01% |
165,100
-100,700
| -38% | -$1.09M |
|
|
LKFT
303
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
| $1.75M | ﹤0.01% |
50,500
-92,810
| -65% | -$2.97M |
|
304
Cerus
CERS
$492M
| $1.75M | ﹤0.01% |
1,100,000
-215,400
| -16% | -$291K |
|
305
Ambarella
AMBA
$3.67B
| $1.72M | ﹤0.01% |
20,900
-1,000
| -5% | -$72.6K |
|
|
SNCY
306
DELISTED
Sun Country Airlines
SNCY
| $1.69M | ﹤0.01% |
143,115
+61,100
| +74% | +$756K |
|
307
Cboe Global Markets
CBOE
$30.3B
| $1.64M | ﹤0.01% |
6,700
-600
| -8% | -$144K |
|
308
Marqeta
MQ
$1.63B
| $1.6M | ﹤0.01% |
75,900
+8,750
| +13% | +$207K |
|
309
Nurix Therapeutics
NRIX
$2.67B
| $1.57M | ﹤0.01% |
170,000
-40,000
| -19% | -$415K |
|
310
Zentalis Pharmaceuticals
ZNTL
$291M
| $1.45M | ﹤0.01% |
962,620
-65,000
| -6% | -$97.4K |
|
311
Greif Class B
GEF.B
$4.18B
| $1.23M | ﹤0.01% |
20,000
-3,000
| -13% | -$202K |
|
312
Valvoline
VVV
$4.28B
| $992K | ﹤0.01% |
27,630
| – | – |
|
313
Wolfspeed
WOLF
$1.56B
| $933K | ﹤0.01% |
32,634
-6,042,479
| -99% | -$14.2M |
|
|
KYNB
314
Kyntra Bio
KYNB
$28.7M
| $721K | ﹤0.01% |
58,879
-30,817
| -34% | -$289K |
|
315
GrowGeneration
GRWG
$85.3M
| $706K | ﹤0.01% |
377,300
| – | – |
|
|
ZIMV
316
DELISTED
ZimVie
ZIMV
| $605K | ﹤0.01% |
31,930
-2,910
| -8% | -$49.2K |
|
317
Medtronic
MDT
$114B
| $364K | ﹤0.01% |
3,820
-445,170
| -99% | -$40.9M |
|
318
Leslie's
LESL
$10.7M
| $361K | ﹤0.01% |
65,556
-1
| -0% | -$7 |
|
|
CRCL
319
Circle Internet Group
CRCL
$16.8B
| $358K | ﹤0.01% |
2,700
| – | – |
|
|
VLRS
320
Controladora Vuela Compania de Aviacion
VLRS
$924M
| $294K | ﹤0.01% |
41,000
| – | – |
|
321
Duolingo
DUOL
$6.31B
| $290K | ﹤0.01% |
900
-2,750
| -75% | -$920K |
|
322
Shutterstock
SSTK
$216M
| $245K | ﹤0.01% |
11,730
-8,629
| -42% | -$176K |
|
323
Standard BioTools
LAB
$306M
| $229K | ﹤0.01% |
176,174
-112,600
| -39% | -$148K |
|
324
Five Below
FIVE
$13.2B
| $201K | ﹤0.01% |
+1,300
| New | +$184K |
|
|
JAMF
325
DELISTED
Jamf
JAMF
| $193K | ﹤0.01% |
18,000
| – | – |
|
Similar funds
VAM
Primecap Management's Q3 2025 Portfolio in Review
As of Q3 2025, Primecap Management held 338 positions worth $131B, up 3.5% from $126B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Primecap Management withdrew a net $8.55B in Q3 2025, closing 11 positions and reducing 234 holdings. Its most notable exit was Hess, an estimated $1.06B position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Primecap Management opened a new position in Chevron worth $988M.
- Primecap Management's largest Q3 2025 buy was Chevron: 6,362,826 shares worth $988M.
- Primecap Management added most to Amazon in Q3 2025, an estimated $718M increase.
- Primecap Management's biggest Q3 2025 reduction was Eli Lilly, cutting an estimated $1.01B.
- Primecap Management fully exited Hess in Q3 2025, selling an estimated $1.06B.
- Primecap Management's ten largest holdings make up 32% of its $131B portfolio in Q3 2025.
- Primecap Management opened 5 new positions and closed 11 in Q3 2025.
- Primecap Management's portfolio value rose 3.5% quarter-over-quarter to $131B.
Based on Primecap Management's 13F filing for Q3 2025, filed 12 Nov 2025.